Literature DB >> 16124707

[Nationwide epidemiological survey regarding heartburn and reflux esophagitis in Japanese].

Syuichi Ohara1, Teruo Kouzu, Tatsuyuki Kawano, Motoyasu Kusano.   

Abstract

The details on prevalence of heartburn and reflux esophagitis have not been clarified, since no large-scale survey has been conducted to date. Accordingly, we conducted the nationwide survey regarding prevalence of heartburn and reflux esophagitis by asking new outpatients and patients with the first endoscopy to be performed who visited the medical institutions participating in this survey to fill out the questionnaire and undergo endoscopy. The result showed that heartburn was reported from 1,994 patients (42.2%) out of 4,723, and reflux esophagitis classified as grade A-D was reported from 602 patients (16.7%) out of 3,608. Meanwhile, fat intake, sweet food and anti-inflammatory analgesics were proven to be causes of heart-burn. Furthermore, frequency of heartburn and severity of reflux esophagitis were slightly correlated, although those were not necessarily obviously related.

Entities:  

Mesh:

Year:  2005        PMID: 16124707

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  16 in total

1.  Natural history and new conceptual framework of gastroesophageal reflux disease.

Authors:  Hiroto Miwa
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

2.  Clinical characteristics of asymptomatic esophagitis.

Authors:  Tsukasa Nozu; Hiroaki Komiyama
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

3.  Erosive esophagitis in asymptomatic subjects: risk factors.

Authors:  Fu-Wei Wang; Ming-Shium Tu; Hung-Yi Chuang; Hsien-Chung Yu; Lung-Chih Cheng; Ping-I Hsu
Journal:  Dig Dis Sci       Date:  2009-08-14       Impact factor: 3.199

4.  Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers.

Authors:  Hatsushi Yamagishi; Tomoyuki Koike; Shuichi Ohara; Toru Horii; Ryousuke Kikuchi; Shigeyuki Kobayashi; Yasuhiko Abe; Katsunori Iijima; Akira Imatani; Kaori Suzuki; Takanori Hishinuma; Junichi Goto; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

Review 5.  Minimal changes in reflux esophagitis: red ones and white ones.

Authors:  Michio Hongo
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

6.  Presence of minimal change esophagitis closely correlates with pathological conditions in the stomach.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Joh Yonemura; Masaaki Okubo; Daisuke Yoshioka; Yoshio Kamiya; Tomiyasu Arisawa; Ichiro Hirata
Journal:  Dig Dis Sci       Date:  2011-11-17       Impact factor: 3.199

7.  Brief Questioning by Nursing Staffs before Endoscopic Examination May Not Always Pick Up Clinical Symptoms of Endoscopic Reflux Esophagitis.

Authors:  Tooru Takashima; Kanako Yamaguchi; Megumi Hara; Tomoko Fukuda; Tsukasa Kuroki; Chie Furushima; Ruriko Wakeshima; Ryuichi Iwakiri; Kazuma Fujimoto; Norie Inoue
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

8.  Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.

Authors:  Hatsushi Yamagishi; Tomoyuki Koike; Shuichi Ohara; Toru Horii; Ryousuke Kikuchi; Shigeyuki Kobayashi; Yasuhiko Abe; Katsunori Iijima; Akira Imatani; Kaori Suzuki; Takanori Hishinuma; Junichi Goto; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

9.  Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population.

Authors:  Motoyasu Kusano; Teruo Kouzu; Tatsuyuki Kawano; Shuichi Ohara
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

Review 10.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.